Page last updated: 2024-11-01

niceritrol and Hypertension

niceritrol has been researched along with Hypertension in 2 studies

Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.

Hypertension: Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Oida, K1
Nakai, T1
Tamai, T1
Kutsumi, Y1
Kobayashi, T1
Hayashi, T1
Yamada, S1
Takeda, R1
Hamazaki, T1
Hasunuma, K1
Kobayashi, S1
Shishido, H1
Yano, S1

Other Studies

2 other studies available for niceritrol and Hypertension

ArticleYear
Effects of niceritrol (pentaerythritol tetranicotinate) on plasma lipoprotein concentration: increment of high density lipoprotein(HDL) cholesterol and HDL-cholesterol/low density lipoprotein cholesterol ratio in hypo-high density lipoproteinemia.
    Artery, 1982, Volume: 10, Issue:4

    Topics: Aged; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Female; Humans; Hypertension; Hypolipoprotein

1982
The effects on lipids, blood viscosity and platelet aggregation of combined use of niceritrol (Perycit) and a low dose of acetylsalicylic acid.
    Atherosclerosis, 1985, Volume: 55, Issue:1

    Topics: Adult; Aged; Arteriosclerosis; Aspirin; Blood Viscosity; Diabetes Mellitus; Female; Fibrinogen; Huma

1985